New drug duo challenges chemo for Tough-to-Treat uterine cancer
NCT ID NCT04865289
Summary
This study tested whether a combination of two newer drugs (pembrolizumab and lenvatinib) works better than standard chemotherapy for women with advanced or recurrent endometrial (uterine) cancer. It involved 130 participants and directly compared how long patients lived without their cancer getting worse and how long they lived overall. The goal was to find a more effective way to control this serious disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIAL NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Anhui Cancer Hospital-Gynecological Oncology ( Site 2509)
Hefei, Anhui, 230031, China
-
Beijing Cancer Hospital ( Site 2504)
Beijing, Beijing Municipality, 100142, China
-
Beijing Obstetrics and Gynecology Hospital Capital Medical University ( Site 2505)
Beijing, Beijing Municipality, 100032, China
-
Chongqing Cancer Hospital ( Site 2513)
Chongqing, Chongqing Municipality, 400030, China
-
Fudan University Shanghai Cancer Center ( Site 2500)
Shanghai, Shanghai Municipality, 200032, China
-
Guang Xi Tumour Hospital, Department of Chemotherapy ( Site 2517)
Nanning, Guangxi, 530021, China
-
Harbin Medical University Cancer Hospital ( Site 2520)
Harbin, Heilongjiang, 150081, China
-
Hubei Cancer Hospital ( Site 2510)
Wuhan, Hubei, 430079, China
-
Hunan Cancer Hospital ( Site 2523)
Changsha, Hunan, 410013, China
-
Jiangxi Maternal and Child Health Hospital ( Site 2519)
Nanchang, Jiangxi, 530021, China
-
Nanjing Maternity and Child Health Care Hospital ( Site 2508)
Nanjing, Jiangsu, 210011, China
-
Obstetrics and Gynecology Hosp. Fudan University ( Site 2503)
Shanghai, Shanghai Municipality, 200090, China
-
Peking Union Medical College Hospital ( Site 2501)
Beijing, Beijing Municipality, 100032, China
-
Shanghai First Maternity and Infant Hospital ( Site 2524)
Shanghai, Shanghai Municipality, 201204, China
-
The First Affiliated Hospital of Xinjiang Medical University ( Site 2515)
Ürümqi, Xinjiang, 830054, China
-
The First Affiliated Hospital.Sun Yat-sen University ( Site 2507)
Guangzhou, Guangdong, 510080, China
-
The First Affiliated hospital of Xiamen University-Obstetrics and gynecology department ( Site 2522)
Xiamen, Fujian, 361003, China
-
The First Hospital Of Jilin University ( Site 2518)
Changchun, Jilin, 130012, China
-
The first affiliated Hospital of Xi an Jiaotong University ( Site 2502)
Xi'an, Shaanxi, 710061, China
-
Women s Hospital School of Medicine Zhejiang University ( Site 2511)
Hangzhou, Zhejiang, 310006, China
-
Xiangya Hospital Central-South University ( Site 2512)
Changsha, Hunan, 410008, China
-
Zhejiang Cancer Hospital ( Site 2506)
Hangzhou, Zhejiang, 310022, China
Conditions
Explore the condition pages connected to this study.